These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 12115018

  • 21. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A, Stimac D, Vceva A, Takac B, Ivandić A, Pezerović D, Horvat D, Nedić P, Kotromanović Z, Maksimović Z, Vranjes Z, Males J, Jurisić-Orzen D, Vladika I, Stimac T, Mandić B.
    Acta Med Croatica; 1999; 53(2):79-82. PubMed ID: 10705625
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F, Morselli-Labate AM, Cappiello R, Ghersi S, Italian Lansoprazole Study Group.
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.
    Chiba N.
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():66B-73B. PubMed ID: 9347181
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM, Prakash A, Faulds D, Lamb HM.
    Drugs; 2003 Sep; 63(1):101-33. PubMed ID: 12487624
    [Abstract] [Full Text] [Related]

  • 31. Lansoprazole for maintenance of remission of erosive oesophagitis.
    Freston JW, Jackson RL, Huang B, Ballard ED.
    Drugs; 2002 Sep; 62(8):1173-84. PubMed ID: 12010078
    [Abstract] [Full Text] [Related]

  • 32. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
    Koop H, Schepp W, Dammann HG, Schneider A, Lühmann R, Classen M.
    J Clin Gastroenterol; 1995 Apr; 20(3):192-5. PubMed ID: 7797824
    [Abstract] [Full Text] [Related]

  • 33. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A, Stimac D, Vceva A, Rubinić M, Ivandić A, Ivanis N, Horvat D, Volarić M, Karner I.
    Acta Med Croatica; 1997 Apr; 51(3):171-4. PubMed ID: 9248117
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
    Stupnicki T, Dietrich K, González-Carro P, Straszak A, Terjung A, Thomas KB, Lühmann R, Fischer R.
    Digestion; 2003 Apr; 68(4):198-208. PubMed ID: 14707396
    [Abstract] [Full Text] [Related]

  • 35. The changing role of H2-receptor antagonists in acid-related diseases.
    Lamers CB.
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis.
    Netzer P, Gut A, Brundler R, Gaia C, Halter F, Inauen W.
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1375-84. PubMed ID: 11552908
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.